19 analysts have expressed a variety of opinions on AbbVie (NYSE:ABBV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 8 | 5 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 5 | 0 | 0 | 0 |
| 2M Ago | 3 | 2 | 3 | 0 | 0 |
| 3M Ago | 2 | 1 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $210.89, a high estimate of $231.00, and a low estimate of $191.00. This upward trend is evident, with the current average reflecting a 2.24% increase from the previous average price target of $206.27.
Exploring Analyst Ratings: An In-Depth...
Login or create a forever free account to read this news
Sign up/Log in
